Results for this period
Interim period (second quarter)1 April 2026–30 September 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Contributions from the Urethane Systems business, higher selling prices for elastomers and other products, increased sales volumes of major products, and solid sales and after-sales service in Functional Products, Resin Chemicals and Machinery. Factors reducing profit included higher income taxes and other taxes, soaring raw material and fuel prices due to the situation in the Middle East, and sluggish sales of contract products and lower royalty income in the Pharmaceuticals business, among others.
None
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026–30 September 2026 |
| Net Sales | ¥244,685 million (YoY +15.0%) |
| Operating profit | ¥12,171 million (YoY +44.2%) |
| Ordinary income | ¥20,480 million (YoY +27.2%) |
| Profit attributable to owners of the parent | ¥10,453 million (YoY -5.7%) |
| Net income per share | ¥107.59 |
| Equity ratio | End of the current fiscal period 46.7% / End of previous period 46.2% |
| Total assets | ¥949,989 million |
| Net assets | ¥460,392 million |
| Cash flows from operating activities | ¥19,413 million |
| Cash flows from investing activities | ¥996 million |
| Cash flows from financing activities | ¥-13,167 million |
| Cash and cash equivalents at end of period | ¥59,896 million |
| Full-year earnings forecast | Net Sales ¥518,000 million (YoY +12.0%) / Operating profit ¥26,500 million (YoY +39.9%) / Ordinary income ¥39,000 million (YoY +4.0%) / Net income ¥25,500 million (YoY +6.8%) |
| Annual Dividend Forecast | ¥110 → ¥160 |
| Segment revenue | Functional products ¥35,071 million (YoY +21.2%), High-performance urethane ¥31,648 million (YoY +86.6%), Pharmaceuticals ¥9,318 million (YoY -9.3%), Resins and chemicals ¥107,598 million (YoY +9.0%), Machinery ¥28,631 million (YoY -2.7%), Other ¥32,419 million (YoY +22.7%) |
| Segment profit | Functional products ¥6,970 million (YoY +61.1%), High-performance urethane ¥415 million, Pharmaceuticals ¥-656 million, Resins and chemicals ¥5,906 million (YoY +46.2%), Machinery ¥2,076 million (YoY +10.1%), Other ¥1,037 million (YoY 0.0%) |
| Depreciation and amortization | ¥13,833 million |
| Impairment loss | ¥588 million |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of property, plant and equipment ¥177 million, Gain on sales of investment securities ¥38 million, Gain on liquidation of an affiliated company ¥882 million / Extraordinary loss Loss on disposal of property, plant and equipment ¥223 million, Loss on sales of investment securities ¥537 million, Impairment loss ¥588 million, Loss on affiliated businesses ¥921 million, Industrial water reduction charge ¥381 million |
| Disclosure regarding the going concern assumption | None |
| Change in accounting policy | Changes due to revisions to standards None / Other changes None / Change in accounting estimate None / Restatement None |
| Changes in the scope of consolidation | New 0 companies / Excluded 0 companies / Company name None |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable Yes / Subject person Analysts and institutional investors |
| Issued Shares at Period-End | 106,200,107 shares |
| Treasury Shares at Period-End | 9,023,386 shares |
| Factors Behind Changes in Business Performance | Contributions from the Urethane Systems business, higher selling prices for elastomers and other products, increased sales volumes of major products, and solid sales and after-sales service in Functional Products, Resin Chemicals and Machinery. Factors reducing profit included higher income taxes and other taxes, soaring raw material and fuel prices due to the situation in the Middle East, and sluggish sales of contract products and lower royalty income in the Pharmaceuticals business, among others. |
Items this document does not state (7)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue increased owing to contributions from the Urethane Systems business, higher selling prices for elastomers, and increased sales volumes of major Functional Products. Operating income increased despite the impact of soaring raw material and fuel prices due to the situation in the Middle East, supported by contributions from the Urethane Systems business and solid sales and after-sales service in Functional Products, Resin Chemicals and Machinery. Interim net income attributable to owners of the parent declined due to higher income taxes and other taxes.